Skip to main content
Journal cover image

Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC).

Publication ,  Conference
Wainberg, Z; Strickler, J; Gordon, M; Barve, M; Wang, L; Yue, H; Motwani, M; Kasichayanula, S; Naumovski, L; Hamilton, E
Published in: Ann Oncol
June 2018

Duke Scholars

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

June 2018

Volume

29 Suppl 5

Start / End Page

v66

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wainberg, Z., Strickler, J., Gordon, M., Barve, M., Wang, L., Yue, H., … Hamilton, E. (2018). Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC). In Ann Oncol (Vol. 29 Suppl 5, p. v66). England. https://doi.org/10.1093/annonc/mdy151.233
Wainberg, Z., J. Strickler, M. Gordon, M. Barve, L. Wang, H. Yue, M. Motwani, S. Kasichayanula, L. Naumovski, and E. Hamilton. “Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC).” In Ann Oncol, 29 Suppl 5:v66, 2018. https://doi.org/10.1093/annonc/mdy151.233.
Wainberg Z, Strickler J, Gordon M, Barve M, Wang L, Yue H, Motwani M, Kasichayanula S, Naumovski L, Hamilton E. Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC). Ann Oncol. 2018. p. v66.
Journal cover image

Published In

Ann Oncol

DOI

EISSN

1569-8041

Publication Date

June 2018

Volume

29 Suppl 5

Start / End Page

v66

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis